Rhythm Pharmaceuticals Inc - Wutah bathi EPS kuartalan RYTM
The transparency of IMCIVREE trials and management's track record with FDA approvals minimize operational risks, which is supported by the historical quarterly EPS growth on GURU.Markets with a metric value of 24.70. Rhythm Pharmaceuticals (RYTM) ensures stable revenue through lifelong treatment of rare genetic obesity, while sufficient capital offsets potential delays in insurance reimbursements for the drug Setmelanotide.
%20Wutah%20bathi%20EPS%20kuartalan&width=1200&height=400&colorIndex=0&v=mwejrfjc.e5f-7d7lczk&start=20220704&end=20261113&filename=GURU_Markets_-_RYTM_-_Rhythm-Pharmaceuticals_-_Quarterly-EPS-earnings-growth "RYTM Wutah bathi EPS kuartalan rhythmtx.com (04.07.2022 - 13.11.2026) | 👁️GURU.Markets👁️")
Rincian metrik keuangan lan pasar Rhythm Corp (RYTM)
- rega saham lan konsensus proyeksi valuasi:
- rincian nilai pasar emiten:
- indikator nilai aset resik miturut neraca:
- data utang lan likuiditas:
Utang marang Ekuitas Rhythm Pharmaceuticals|RYTM - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Rhythm Pharmaceuticals|RYTM - Gunggung kewajiban utang perusahaan|Rasio utang marang kapitalisasi buku Rhythm Pharmaceuticals Inc|RYTM - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Rhythm Pharmaceuticals|Likuiditas cepet rhythmtx.com
- indikator bathi lan kelipatan valuasi:
RYTM - Bathi pungkasan|Proyeksi bathi mangsa ngarep Rhythm Pharmaceuticals|RYTM - Nilai perusahaan marang bathi resik|Prakiraan rega marang bathi Rhythm Pharmaceuticals Inc|RYTM - Rega marang bathi kanthi panyesuaian wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Rhythm Pharmaceuticals Inc|RYTM - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi resik saben saham (EPS TTM) Rhythm Pharmaceuticals|RYTM - Bathi saben saham sajroning taun lumaku|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan rhythmtx.com|RYTM - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep Rhythm Pharmaceuticals
Analisis kabeh metrik perusahaan:Rhythm Pharmaceuticals
Conservative capital demands absolute transparency regarding operational efficiency and earnings sustainability. This indicator measures quarterly net income per share dynamics, revealing the business's real margins after accounting for inflationary pressure. The orphan drug status of Rhythm Pharmaceuticals (RYTM) minimizes competition, ensuring a stable cash flow. GURU.Markets analysts recommend using the quarterly earnings per share growth chart to assess the scaling of this advantage. The trend of this metric confirms the company's fundamental value.
Pesaing Rhythm Pharmaceuticals (RYTM)
ASND (Ascendis Pharma) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|MDGL: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|CORT (Corcept) - Wutah bathi EPS kuartalan|Wutah bathi EPS kuartalan Akero Corp|Wutah bathi EPS kuartalan MTSR|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan MLTX (moonlaketx.com)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Crinetics CRNX|NewAmsterdam Pharma Company (NAMS) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|SLNO - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|FOLD: Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|ETNB: Wutah bathi EPS kuartalan|AGIO - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Structure Therapeutics Inc.|MiMedx Group Inc (MDXG) - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Rezolute Corp (RZLT)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan Lexicon Corp LXRX|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan MBX Biosciences Inc MBX|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan ALT|Aardvark Therapeutics - Wutah bathi EPS kuartalan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan SGMT (Sagimet Biosciences, Inc.)|BIOA (BioAge Labs Inc.) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Biomea Fusion Corp (BMEA)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan QNCX|GUTS (fractyl.com) - Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan VTVT|ATPC (agapeatpgroup.com) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Pluri PLUR|SYBX - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|LPCN: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan MTNB (Matinas BioPharma)|Spruce Biosciences (SPRB) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan GLTO (Galecto Inc)|CTCX (Carmell Corp) - Wutah bathi EPS kuartalan|LUMO: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan ONVO|Wutah bathi EPS kuartalan radiuspharm.com (RDUS)
